Insider Trading activities of Critical Therapeutics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Critical Therapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Critical Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Critical Therapeutics Inc since 2005. The reporting company's ticker symbol is CRTX. The reporting company's CIK number is 1145404.
The total value of stock buying since 2005 is $35,104,214.
The total value of stock sales since 2005 is $37,772,725.
The total value of stock option exercises since 2005 is $405,757.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Critical Therapeutics Inc (CRTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2012-08 0 $0 63,325 $438,111 63,325 $246,967
2012-04 1,443,913 $9,024,456 1,443,913 $9,024,456 0 $0
2012-03 10,200 $60,924 0 $0 0 $0
2011-07 0 $0 2,000 $17,260 0 $0
2011-05 0 $0 5,850 $44,460 0 $0
2011-04 0 $0 2,000 $13,060 0 $0
2011-01 0 $0 2,000 $11,460 0 $0
2010-12 0 $0 450,000 $2,709,000 0 $0
2010-11 0 $0 7,900 $49,612 0 $0
2010-06 0 $0 4,129 $22,585 0 $0
2009-09 0 $0 173,100 $1,219,460 8,100 $31,589
2009-07 0 $0 2,850,000 $15,675,000 0 $0
2009-06 0 $0 119,041 $992,165 0 $0
2009-05 0 $0 44,972 $291,634 134,041 $57,637
2007-08 9,000 $18,816 0 $0 0 $0
2007-06 0 $0 2,281,022 $5,941,159 1,389 $527
2007-04 0 $0 0 $0 21,356 $22,423
2006-08 0 $0 14,500 $58,104 10,500 $11,025
2006-03 0 $0 18,500 $99,764 77,933 $32,964
2006-02 0 $0 10,500 $59,418 2,500 $2,625
2006-01 0 $0 26,000 $170,290 0 $0
2005-12 0 $0 26,000 $172,609 0 $0
2005-11 0 $0 26,000 $179,394 0 $0
2005-10 0 $0 67,000 $554,214 0 $0
2005-09 0 $0 5,000 $29,510 0 $0
2005-06 4,744,529 $26,000,018 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Critical Therapeutics Inc insiders (CRTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-08-29 Franklin Joshua B (VP, Strategy & Bus. Dev.) Sale 38,637 6.86 265,049
2012-08-29 Franklin Joshua B (VP, Strategy & Bus. Dev.) Option Ex 38,637 3.90 150,684
2012-08-24 Franklin Joshua B (VP, Strategy & Bus. Dev.) Sale 24,688 7.01 173,062
2012-08-24 Franklin Joshua B (VP, Strategy & Bus. Dev.) Option Ex 24,688 3.90 96,283
2012-04-03 Chiesi Farmaceutici Spa (10% Owner) Buy 1,443,913 6.25 9,024,456
2012-04-03 Collard Craig A (Chief Executive Officer) Sale 1,443,913 6.25 9,024,456
2012-03-15 Chiesi Farmaceutici Spa (10% Owner) Buy 3,400 6.08 20,672
2012-03-14 Chiesi Farmaceutici Spa (10% Owner) Buy 3,400 5.99 20,366
2012-03-12 Chiesi Farmaceutici Spa (10% Owner) Buy 3,400 5.85 19,886
2011-07-15 Powell Andrew Kenneth William (EVP, General Counsel) Sale 2,000 8.63 17,260
2011-05-26 Roberts Alan (VP, Scientific Affairs) Sale 5,850 7.60 44,460
2011-04-04 Powell Andrew Kenneth William (EVP, General Counsel) Sale 2,000 6.53 13,060
2011-01-07 Powell Andrew Kenneth William (EVP, General Counsel) Sale 2,000 5.73 11,460
2010-12-16 Lutz Steven Michael (Executive Vice President) Sale 65,000 6.02 391,300
2010-12-16 Collard Craig A (President and CEO) Sale 385,000 6.02 2,317,700
2010-11-01 Powell Andrew Kenneth William (EVP, General Counsel) Sale 7,900 6.28 49,612
2010-06-01 Franklin Joshua B (VP, Sales and Marketing) Sale 4,129 5.47 22,585
2009-09-11 Franklin Joshua B (VP, Sales and Marketing) Sale 5,883 7.56 44,475
2009-09-11 Franklin Joshua B (VP, Sales and Marketing) Option Ex 5,883 3.90 22,943
2009-09-10 Franklin Joshua B (VP, Sales and Marketing) Sale 2,217 7.49 16,605
2009-09-10 Franklin Joshua B (VP, Sales and Marketing) Option Ex 2,217 3.90 8,646
2009-09-03 Price David (Chief Financial Officer) Sale 112,000 7.06 791,280
2009-09-02 Dickson Brian (Chief Medical Officer) Sale 15,000 6.74 101,100
2009-09-01 Price David (Chief Financial Officer) Sale 38,000 7.00 266,000
2009-07-28 Lutz Steven Michael (Executive Vice President) Sale 350,000 5.50 1,925,000
2009-07-28 Cornerstone Biopharma Holdings, Ltd. (10% Owner) Sale 1,250,000 5.50 6,875,000
2009-07-28 Collard Craig A (President and CEO) Sale 1,250,000 5.50 6,875,000
2009-06-19 Mcewan Alastair Stuart (Director) Sale 8,141 9.00 73,269
2009-06-15 Mcewan Alastair Stuart (Director) Sale 43,316 8.51 368,619
2009-06-12 Mcewan Alastair Stuart (Director) Sale 3,388 8.51 28,831
2009-06-11 Mcewan Alastair Stuart (Director) Sale 300 8.50 2,550
2009-06-10 Mcewan Alastair Stuart (Director) Sale 6,865 8.50 58,352
2009-06-09 Mcewan Alastair Stuart (Director) Sale 17,031 8.50 144,763
2009-06-08 Mcewan Alastair Stuart (Director) Sale 36,700 7.93 291,031
2009-06-05 Mcewan Alastair Stuart (Director) Sale 3,300 7.50 24,750
2009-05-29 Dickson Brian (Chief Medical Officer) Option Ex 15,000 .43 6,450
2009-05-18 Townsend Scott B (GENERAL COUNSEL and EVP LEGAL) Sale 5,600 6.50 36,400
2009-05-18 Mcewan Alastair Stuart (Director) Option Ex 119,041 .43 51,187
2009-05-15 Townsend Scott B (GENERAL COUNSEL and EVP LEGAL) Sale 13,000 6.63 86,190
2009-05-14 Townsend Scott B (GENERAL COUNSEL and EVP LEGAL) Sale 26,372 6.41 169,044
2007-08-22 Kelly Thomas Patrick (CFO & SVP Finance & Corp. Dev,) Buy 4,000 2.08 8,316
2007-08-22 Thomas Frank E (President & CEO) Buy 5,000 2.10 10,500
2007-06-25 Phillips Trevor (COO and SVP of Operations) Option Ex 1,389 .38 527
2007-06-14 Tananbaum James B (Director) Sale 195,751 2.29 448,661
2007-06-13 Tananbaum James B (Director) Sale 300,000 2.23 669,000
2007-06-12 Tananbaum James B (Director) Sale 60,910 2.38 144,843
2007-06-11 Tananbaum James B (Director) Sale 2,400 2.50 6,000
2007-06-08 Tananbaum James B (Director) Sale 288,000 2.50 720,575
2007-06-07 Tananbaum James B (Director) Sale 1,000 2.68 2,680
2007-06-06 Tananbaum James B (Director) Sale 330,794 2.69 889,174
2007-06-05 Tananbaum James B (Director) Sale 387,500 2.66 1,032,300
2007-06-04 Tananbaum James B (Director) Sale 315,773 2.76 871,533
2007-06-01 Tananbaum James B (Director) Sale 398,894 2.90 1,156,393
2007-04-06 Warren Howland Shaw (Director) Option Ex 21,356 1.05 22,423
2006-08-09 Phillips Trevor (COO and SVP of Operations) Sale 10,500 3.99 41,853
2006-08-09 Phillips Trevor (COO and SVP of Operations) Option Ex 10,500 1.05 11,025
2006-08-08 Phillips Trevor (COO and SVP of Operations) Sale 4,000 4.06 16,251
2006-03-28 Warren Howland Shaw (Director) Sale 8,000 5.03 40,208
2006-03-22 Rubin Paul D (President and CEO) Option Ex 72,933 .38 27,714
2006-03-14 Warren Howland Shaw (Director) Sale 8,000 5.57 44,544
2006-03-06 Phillips Trevor (COO and SVP of Operations) Sale 2,500 6.00 15,012
2006-03-06 Phillips Trevor (COO and SVP of Operations) Option Ex 5,000 1.05 5,250
2006-02-28 Warren Howland Shaw (Director) Sale 8,000 5.42 43,368
2006-02-01 Phillips Trevor (COO and SVP of Opera) Sale 2,500 6.42 16,050
2006-02-01 Phillips Trevor (COO and SVP of Opera) Option Ex 2,500 1.05 2,625
2006-01-30 Rubin Paul D (President and CEO) Sale 5,000 6.53 32,650
2006-01-24 Warren Howland Shaw (Director) Sale 8,000 6.30 50,440
2006-01-17 Rubin Paul D (President and CEO) Sale 5,000 6.67 33,360
2006-01-10 Warren Howland Shaw (Director) Sale 8,000 6.73 53,840
2005-12-27 Warren Howland Shaw (Director) Sale 8,000 6.71 53,664
2005-12-15 Rubin Paul D (President and CEO) Sale 5,000 6.72 33,600
2005-12-13 Warren Howland Shaw (Director) Sale 8,000 6.74 53,960
2005-12-02 Phillips Trevor (COO and SVP of Opera) Sale 5,000 6.28 31,385
2005-11-22 Warren Howland Shaw (Director) Sale 8,000 6.53 52,240
2005-11-15 Rubin Paul D (President and CEO) Sale 5,000 6.80 33,980
2005-11-08 Warren Howland Shaw (Director) Sale 8,000 7.55 60,384
2005-11-02 Phillips Trevor (COO and SVP of Opera) Sale 5,000 6.56 32,790
2005-10-31 Rubin Paul D (President and CEO) Sale 10,000 7.01 70,120
2005-10-25 Warren Howland Shaw (Director) Sale 8,000 8.71 69,712
2005-10-17 Rubin Paul D (President and CEO) Sale 10,000 8.65 86,545
2005-10-11 Warren Howland Shaw (Director) Sale 16,000 8.51 136,128
2005-10-03 Phillips Trevor (COO and SVP of Opera) Sale 5,000 9.06 45,290
2005-09-19 Phillips Trevor (COO and SVP of Opera) Sale 5,000 5.90 29,510
2005-06-20 Atv Associates Vi, L.l.c. (10% Owner) Buy 1,277,373 5.48 7,000,004
2005-06-20 George Jean (Director) Buy 1,277,373 5.48 7,000,004
2005-06-20 Miraelli Christopher (Director) Buy 1,094,891 5.48 6,000,002
2005-06-20 Galakatos Nicholas (Director) Buy 547,446 5.48 3,000,004
2005-06-20 Evnin Luke (10% Owner) Buy 547,446 5.48 3,000,004

Insider trading activities including stock purchases, stock sales, and option exercises of CRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Critical Therapeutics Inc (symbol CRTX, CIK number 1145404) see the Securities and Exchange Commission (SEC) website.